These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21158459)

  • 1. Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
    Lam AR; Bhattacharya S; Patel K; Hall SE; Mao A; Vaidehi N
    J Chem Inf Model; 2011 Jan; 51(1):139-47. PubMed ID: 21158459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
    Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
    J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
    Gerlach LO; Skerlj RT; Bridger GJ; Schwartz TW
    J Biol Chem; 2001 Apr; 276(17):14153-60. PubMed ID: 11154697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
    Gerlach LO; Jakobsen JS; Jensen KP; Rosenkilde MR; Skerlj RT; Ryde U; Bridger GJ; Schwartz TW
    Biochemistry; 2003 Jan; 42(3):710-7. PubMed ID: 12534283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.
    Rosenkilde MM; Gerlach LO; Jakobsen JS; Skerlj RT; Bridger GJ; Schwartz TW
    J Biol Chem; 2004 Jan; 279(4):3033-41. PubMed ID: 14585837
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
    J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
    Wong RS; Bodart V; Metz M; Labrecque J; Bridger G; Fricker SP
    Mol Pharmacol; 2008 Dec; 74(6):1485-95. PubMed ID: 18768385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme.
    Hunter TM; McNae IW; Liang X; Bella J; Parsons S; Walkinshaw MD; Sadler PJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2288-92. PubMed ID: 15701702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
    Labrosse B; Brelot A; Heveker N; Sol N; Schols D; De Clercq E; Alizon M
    J Virol; 1998 Aug; 72(8):6381-8. PubMed ID: 9658078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.
    Pettersson S; Pérez-Nueno VI; Mena MP; Clotet B; Esté JA; Borrell JI; Teixidó J
    ChemMedChem; 2010 Aug; 5(8):1272-81. PubMed ID: 20533501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.
    Hatse S; Princen K; Vermeire K; Gerlach LO; Rosenkilde MM; Schwartz TW; Bridger G; De Clercq E; Schols D
    FEBS Lett; 2003 Jul; 546(2-3):300-6. PubMed ID: 12832058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bicyclam AMD3100 story.
    De Clercq E
    Nat Rev Drug Discov; 2003 Jul; 2(7):581-7. PubMed ID: 12815382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor.
    Liang X; Parkinson JA; Weishäupl M; Gould RO; Paisey SJ; Park HS; Hunter TM; Blindauer CA; Parsons S; Sadler PJ
    J Am Chem Soc; 2002 Aug; 124(31):9105-12. PubMed ID: 12149014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.
    De Clercq E
    Mini Rev Med Chem; 2005 Sep; 5(9):805-24. PubMed ID: 16178723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors.
    Pettersson S; Pérez-Nueno VI; Ros-Blanco L; Puig de La Bellacasa R; Rabal MO; Batllori X; Clotet B; Clotet-Codina I; Armand-Ugón M; Esté J; Borrell JI; Teixidó J
    ChemMedChem; 2008 Oct; 3(10):1549-57. PubMed ID: 18671217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.
    Ross A; Soares DC; Covelli D; Pannecouque C; Budd L; Collins A; Robertson N; Parsons S; De Clercq E; Kennepohl P; Sadler PJ
    Inorg Chem; 2010 Feb; 49(3):1122-32. PubMed ID: 20039648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities.
    Poty S; Désogère P; Goze C; Boschetti F; D'huys T; Schols D; Cawthorne C; Archibald SJ; Maëcke HR; Denat F
    Dalton Trans; 2015 Mar; 44(11):5004-16. PubMed ID: 25640878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.
    Jacobson O; Weiss ID; Szajek L; Farber JM; Kiesewetter DO
    Bioorg Med Chem; 2009 Feb; 17(4):1486-93. PubMed ID: 19188071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t.
    Ward RJ; Pediani JD; Marsango S; Jolly R; Stoneman MR; Biener G; Handel TM; Raicu V; Milligan G
    J Biol Chem; 2021; 296():100139. PubMed ID: 33268380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.